产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 51905 | CPI-613(Devimistat ) | 95809-78-2 | ≧98.0% |  |
| CPI-613( Devimistat ) is an E1 pyruvate dehydrogenase (PDH) modulator that prevents c | ||||
| 52023 | DCC-2036(Rebastinib) | 1020172-07-9 | 98% | _1020172-07-9.png) |
| Rebastinib(DCC-2036;DCC2036) is an inhibitor of tyrosine kinases TIE2 and ABL1.Rebast | ||||
| 52021 | Ganetespib(STA-9090) | 888216-25-9 | 98% |  |
| Ganetespib blocked the ability of HSP90 to bind to biotinylated geldanamycin and disr | ||||
| 52019 | GSK 2656157 | 1337532-29-2 | 98% |  |
| GSK2656157 is an ATP-competitive and highly selective inhibitor ofPERKwithIC50of 0.9 | ||||
| 2073103 | Remibrutinib ( LOU064 ) | 1787294-07-8 | 98% Min. | .png) |
| Remibrutinib ( LOU064 ) is a Potent and Highly Selective Covalent Inhibitor of Bruton | ||||
| 51608 | SSR128129E | 848318-25-2 | 98% |  |
| SSR128129E is an orally-active and allostericFGFR1inhibitor withIC50of 1.9 M, while n | ||||
| 51803 | Semaxanib (SU5416) | 204005-46-9 | 98% | -cas-204005-46-9.png) |
| Semaxanib (SU5416) is a potent and selectiveVEGFR(Flk-1/KDR) inhibitor withIC50of 1.2 | ||||
| 51607 | VE-822 ( Berzosertib ) | 1232416-25-9 | ≧98.0% | _1232416-25-9.png) |
| VE-822(Berzosertib), an analogue of VE-821 with increased potency and selectivity aga | ||||
| 52003 | Zosuquidar trihydrochloride | 167465-36-3 | 99% |  |
| zosuquidar trihydrochloride is adifluorocyclopropyl quinoline. Zosuquidar trihydrochl | ||||
| 52002 | K-7174 dihydrochloride | 191089-60-8 | 98% |  |
| K-7174 dihydrochloride is a novel cell adhesion inhibitor; inhibits the expression of | ||||
| 52105 | SNS-032 ( BMS-387032 ) | 345627-80-7 | 98% |  |
| SNS-032 has firstly been described as a selective inhibitor ofCDK2withIC50of 48 nM an | ||||
| 51614 | AMG-925 | 1401033-86-0 | 98% |  |
| AMG-925 is a potent and orally bioavailable dual inhibitor of CDK4 and FLT3, includin | ||||